Markets had expected the central bank to keep its benchmark interest rate steady while setting up a cut at the July meeting.The Fedread more
The stream is slated to start at 2:30 pm ETThe Fedread more
This is a comparison of Wednesday's FOMC statement with the one issued on May 1 after the Fed's previous policy-making meeting.The Fedread more
Powell said policymakers are concerned about some of the recent economic developments and see a growing case for easier policy.The Fedread more
The Fed chief said that despite reports that Trump was looking to demote or fire him, he doesn't plan on leaving anytime soon.The Fedread more
Federal Reserve Chairman Jerome Powell said the case for a rate cut at central bank's Wednesday meeting is not strong enough.The Fedread more
If you're concerned about what Wednesday's Fed decision means for your bank account, mortgage loan or credit card — as well as student debt, home equity loan and car payment —...Personal Financeread more
The Federal Open Market Committee's quarterly economic forecast includes the so-called dot plot of where members see interest rates heading.The Fedread more
Employees spoke out on issues such as forced arbitration, workplace equity and Project Dragonfly at Alphabet's annual shareholder meeting.Technologyread more
The Federal Reserve lowered its inflation forecast for 2019 while keeping the growth expectations unchanged.The Fedread more
With bold and targeted steps, economists say, government can increase opportunity and incomes for many more people in ways that strengthen, not weaken, American capitalism.Politicsread more
Medtronic's fourth-quarter profit topped analysts' estimates on Thursday on higher demand for heart valves and diabetes devices such as insulin pumps.
Medtronic, the world's largest standalone medical device maker, sells everything from minimally invasive therapies to spinal and heart devices, and it has been launching new products to combat increasingly fierce competition.
The company on Thursday also forecast an adjusted profit of $5.10 to $5.15 per share for fiscal 2019, in line with analysts' average estimate of $5.14, according to Thomson Reuters I/B/E/S.
Evercore's Kumar said that considering recent concerns over currency movements, the in-line forecast should provide relief for investors.
The company's shares rose 1 percent in premarket trading.
Cardiac and vascular unit sales jumped 10.1 percent to $3.14 billion in the fourth quarter, beating the average analyst estimate of $3.10 billion.
Sales at Medtronic's coronary & structural heart unit, which houses the transcatheter valves, rose 18.7 percent to $1.01 billion.
The company's diabetes unit sales rose 26 percent to $645 million, helped by strong demand for its new sensor-augmented insulin pump systems.
Net income attributable to the company jumped 25.5 percent to $1.46 billion, or $1.07 per share, in the quarter ended April 27.
Excluding items, the company earned $1.42 per share, beating the average analyst estimate of $1.39.
Revenue rose 2.9 percent to $8.14 billion.